[TOR inhibitors for immunosuppression].
Heinzl
S
S
Redaktion Medizinische Monatsschrift für Pharmazeuten, Stuttgart. sheinzl@wissenschaftliche-verlagsgesellschaft.de
D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology*; D017853:Phosphotransferases (Alcohol Group Acceptor) / Q000037:antagonists & inhibitors*; D011494:Protein Kinases; D020123:Sirolimus / Q000627:therapeutic use*; D058570:TOR Serine-Threonine Kinases
D007166:Immunosuppressive Agents; D011494:Protein Kinases; D017853:Phosphotransferases (Alcohol Group Acceptor); C546842:MTOR protein, human; D058570:TOR Serine-Threonine Kinases; D020123:Sirolimus